Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Utility of Rapid Whole-Genome Sequencing in Hospitalized Adults With Unexplained Neurologic Presentations.

Neurology·2026
Same author

Development of a large porcine model of osteogenesis imperfecta type I.

Bone reports·2026
Same author

Vascular Tumors Result from Adeno-Associated Virus-9 Angiogenic Gene Therapy of Bone Allografts.

Vascular cell·2025
Same author

Semiautomated approach focused on new genomic information results in time and effort-efficient reannotation of negative exome data.

Human genetics·2024
Same author

Thoracic Aortic Aneurysmal Disease: Comprehensive Recommendations for the Primary Care Physician.

Mayo Clinic proceedings·2024
Same author

Impact of Genetic Disorders in the Surgical Management of Congenital Heart Disease.

World journal for pediatric & congenital heart surgery·2023

Related Experiment Video

Updated: Jun 11, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Nonintegrating foamy virus vectors.

David R Deyle1, Yi Li, Erik M Olson

  • 1Department of Medicine, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA.

Journal of Virology
|July 2, 2010
PubMed
Summary
This summary is machine-generated.

Nonintegrating foamy virus (NIFV) vectors were created for transient gene expression. These episomal vectors efficiently transduce cells, express genes, and are diluted in dividing populations, offering a safer alternative to integrating vectors.

More Related Videos

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Related Experiment Videos

Last Updated: Jun 11, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Area of Science:

  • Retroviral vector development
  • Molecular biology
  • Gene therapy

Background:

  • Foamy viruses (FVs) are integrating retroviruses historically used as gene delivery vectors.
  • The integrase enzyme is crucial for FV integration into the host genome.
  • Developing nonintegrating vectors is essential for applications requiring transient gene expression and enhanced safety.

Purpose of the Study:

  • To engineer nonintegrating foamy virus (NIFV) vectors by disrupting the integrase catalytic core motif.
  • To characterize the properties of NIFV vectors, including their integration status, episomal forms, and transgene expression capabilities.
  • To demonstrate the utility of NIFV vectors in gene editing applications.

Main Methods:

  • Point mutations were introduced into the DD35E motif of the FV integrase sequence to create NIFV vectors.
  • High-titer NIFV stocks were produced and used to transduce dividing cells.
  • Vector genome forms (episomal: linear, 1-LTR, 2-LTR circles) were analyzed post-transduction.
  • Integration frequency of NIFV vectors was compared to wild-type FV vectors.
  • Cre recombinase expression from an NIFV vector was used to mediate gene excision.

Main Results:

  • NIFV vectors were successfully generated, producing high-titer stocks and transducing dividing cells without significant integration.
  • Infected cells harbored stable, episomal vector genomes (linear, 1-LTR, 2-LTR circles) that expressed transgenes and were diluted over time.
  • 1-LTR circles were present in vector stocks prior to infection, while residual integration was 4 logs lower than wild-type FV vectors.
  • NIFV vectors expressing Cre recombinase facilitated efficient excision of target DNA sequences, validating their utility.

Conclusions:

  • NIFV vectors represent a novel class of nonintegrating, episomal gene delivery vehicles.
  • These vectors offer transient gene expression with reduced risk of insertional mutagenesis compared to integrating FV vectors.
  • The broad host range and large packaging capacity of NIFV vectors make them promising tools for various gene therapy and research applications.